Researcher Christopher Matthews works in a Takeda California lab. Takeda acquired Envoy Therapeutics in a deal worth $140 million.

Researcher Christopher Matthews works in a Takeda California lab. Takeda acquired Envoy Therapeutics in a deal worth $140 million.

TAKEDA CALIFORNIA INC.

CEO: Keith Wilson, president and chief scientific officer.

Revenue: Not applicable. Takeda California is a drug discovery research division of Takeda Pharmaceutical Co. Ltd.

No. of local employees: 200.

Headquarters: La Jolla.

Year founded: Takeda San Diego was formed in 2005 following Takeda’s purchase of local biotechnology company Syrrx. Takeda San Diego was renamed Takeda California in January 2012.

Company description: Takeda California designs innovative new medicines to treat cancer, and various metabolic and immune disorders.

Key factors for success: A strong commitment to innovation in drug discovery. Community involvement.

La Jolla-based Takeda California Inc...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129